SCHEMBL23774397

SCHEMBL23774397

O=C(NCc1ccc(CN2CCc3cc(OCC4CC4)ccc3C2)cc1)C1(O)CC1

nearest known ligand 0.74

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ACACB O00763 20/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23774152 0.88 ACACB (0.74) ACACB
SCHEMBL23774224 0.87 ACACB (0.68) ACACB
SCHEMBL23774191 0.87 ACACB (0.73) ACACB
SCHEMBL17585268 0.85 ACACB (1.00) ACACB
SCHEMBL23774289 0.84 ACACB (0.78) ACACB
SCHEMBL23774146 0.84 ACACB (0.61) ACACB
SCHEMBL23774279 0.83 ACACB (0.74) ACACB
SCHEMBL23774373 0.83 ACACB (0.63) ACACB
SCHEMBL23774255 0.83 ACACB (0.76) ACACB
SCHEMBL23774182 0.82 ACACB (0.66) ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3194367-B1 TETRAHYDROISOQUINOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS USEFUL FOR THE TREATMENT OF OBESITY AND DIABETES BOEHRINGER INGELHEIM INT (DE) 2021-08-18 EP disclosed